Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-19 4:57 PM View:  | Esperion Therapeutics, Inc. (ESPR) | 12-Mar-19 | Market Sale (Planned) | 25,000 | $50.06 | $1,251,500.00 | (4%) 573.73K to 548.73K | 44% |
| 02-Nov-18 5:00 PM View: | Esperion Therapeutics, Inc. (ESPR) | 02-Nov-18 | Market Sale (Planned) | 227 | $50.76 | $11,522.50 | (< 1%) 573.95K to 573.73K | 45% |
| 02-Nov-18 5:00 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Nov-18 | Market Sale (Planned) | 2,600 | $50.01 | $130,026.00 | (< 1%) 576.55K to 573.95K | 44% |
| 18-Oct-18 5:05 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Oct-18 | Market Sale (Planned) | 100 | $50.00 | $5,000.00 | (< 1%) 576.65K to 576.55K | 44% |
| 18-Oct-18 5:05 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Oct-18 | Market Sale (Planned) | 12,673 | $50.02 | $633,903.00 | (2%) 589.33K to 576.65K | 44% |
| 18-Oct-18 5:05 PM View: | Esperion Therapeutics, Inc. (ESPR) | 16-Oct-18 | Market Sale (Planned) | 9,400 | $50.01 | $470,094.00 | (2%) 598.73K to 589.33K | 44% |
| 29-Aug-18 4:56 PM View: | Esperion Therapeutics, Inc. (ESPR) | 27-Aug-18 | Market Sale (Planned) | 17,700 | $51.05 | $903,610.00 | (3%) 616.43K to 598.73K | 45% |
| 22-Aug-18 7:18 AM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Aug-18 | Market Sale (Planned) | 7,300 | $50.06 | $365,438.00 | (1%) 623.73K to 616.43K | 44% |
| 29-Mar-18 7:47 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-Mar-18 | Market Sale (Planned) | 15,956 | $71.87 | $1,146,710.00 | 3% 616.81K to 632.77K | (61%) |
| 29-Mar-18 7:47 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-Mar-18 | Market Sale (Planned) | 9,044 | $73.26 | $662,563.00 | (1%) 632.77K to 623.73K | 62% |
| 09-Feb-18 5:47 PM View: | Esperion Therapeutics, Inc. (ESPR) | 07-Feb-18 | Payment of Exercise | 3,608 | $6.99 | $25,219.90 | (< 1%) 652.33K to 648.73K | |
| 09-Feb-18 5:47 PM View: | Esperion Therapeutics, Inc. (ESPR) | 07-Feb-18 | Option Exercise | 34,651 | $6.99 | $242,210.00 | 6% 617.68K to 652.33K | |
| 09-Feb-18 5:47 PM View: | Esperion Therapeutics, Inc. (ESPR) | 12-Dec-17 | Gift | 12,000 | -- | -- | (2%) 629.68K to 617.68K | |
| 01-Jul-13 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion | 301,051 | -- | -- | 105% 286.29K to 587.34K | |
| 01-Jul-13 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase | 42,346 | $14.00 | $592,844.00 | 7% 587.34K to 629.68K | |
| 10-Feb-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 05-Feb-04 | Option Exercise | 137,630 | -- | -- | 38% 366.05K to 503.68K | |
| 10-Feb-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 05-Feb-04 | Disposition (change in control) | 503,677 | $35.00 | $17,628,700.00 | (100%) 503.68K to 0 | |
| 10-Feb-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 30-Dec-03 | Gift | 206,500 | -- | -- | (36%) 572.55K to 366.05K | |
| 28-Aug-03 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 26-Aug-03 | Sale | 95,000 | $16.00 | $1,520,000.00 | (14%) 667.29K to 572.29K |